Norris Medicines Limited (BOM:524414)

Market Cap	155.81M -9.7%
Revenue (ttm)	75.77M +15.6%
Net Income	-3.67M
EPS	-0.37
Shares Out	10.00M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	895
Open	15.73
Previous Close	15.58
Day's Range	15.50 - 16.35
52-Week Range	12.00 - 19.63
Beta	-0.49
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About Norris Medicines

Norris Medicines Limited manufactures and sells pharmaceutical formulations in India. The company offers nonsterile dosage products, such as tablets, capsules, liquid orals, and copical ointments, as well as injections and medicinal formulations. Its products include antibiotics, anti-inflammatory/pain management, antiemetic, nutrition, gastro, cough/cold, skin and allergy, antimalarial, diabetic, cardiac, dental, and other medicine products. The company also provides contract and loan license manufacturing services for pharma companies. It exp...

• Industry: Pharmaceutical Preparations
• Founded: 1990
• Employees: 33
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524414

Financial Performance

In fiscal year 2026, Norris Medicines's revenue was 81.32 million, an increase of 39.72% compared to the previous year's 58.20 million. Losses were -2.81 million, -77.33% less than in 2025.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 18, 2026

Data Sources Report a data error